Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials
- PMID: 28728654
- DOI: 10.1016/j.jcin.2017.04.037
Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials
Abstract
Objectives: The aim of this study was to compare long-term survival between patients with severe coronary artery disease undergoing coronary artery bypass grafting (CABG) and those undergoing percutaneous coronary intervention (PCI) achieving complete revascularization (CR) or incomplete revascularization.
Background: The importance of CR in decision making regarding revascularization strategy in patients with severe coronary artery disease is unknown.
Methods: Data were pooled from the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) trials. The primary outcome was death from any cause and was compared in an as-treated analysis.
Results: The rate of CR was 61.7% (57.2% with PCI and 66.8% with CABG). During a median 4.9-year follow-up period (interquartile range: 4.5 to 5.0 years), compared with patients undergoing CABG with CR, those undergoing PCI with incomplete revascularization had a higher risk for death from any cause (adjusted hazard ratio [aHR]: 1.43; 95% confidence interval [CI]: 1.03 to 2.00; p = 0.036) and the composite of death, myocardial infarction, and stroke (aHR: 1.48; 95% CI: 1.14 to 1.92; p = 0.003). However, there was no significant difference between patients undergoing CABG with CR and those undergoing PCI with CR regarding the risk for death from any cause (aHR: 1.16; 95% CI: 0.83 to 1.63; p = 0.39) and the composite of death, myocardial infarction, and stroke (aHR: 1.14; 95% CI: 0.87 to 1.48; p = 0.35). Subgroup analysis of multivessel coronary disease, high SYNTAX score (>32), and diabetes showed consistent findings.
Conclusions: For the treatment of left main or multivessel coronary artery disease, PCI resulting in CR was associated with a similar long-term survival rate to CABG resulting in CR. Therefore, the ability to achieve CR should enter into the decision algorithm for choice of revascularization strategy.
Keywords: bypass surgery; coronary artery disease; stenting.
Copyright © 2017. Published by Elsevier Inc.
Comment in
-
Complete Coronary Revascularization: The End Justifies the Means, as Long as Something Justifies the End.JACC Cardiovasc Interv. 2017 Jul 24;10(14):1425-1427. doi: 10.1016/j.jcin.2017.06.003. JACC Cardiovasc Interv. 2017. PMID: 28728655 No abstract available.
Similar articles
-
Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008. JACC Cardiovasc Interv. 2016. PMID: 28007199
-
Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.JACC Cardiovasc Interv. 2016 Aug 8;9(15):1564-72. doi: 10.1016/j.jcin.2016.04.023. JACC Cardiovasc Interv. 2016. PMID: 27491605 Clinical Trial.
-
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071. J Am Coll Cardiol. 2018. PMID: 30025574
-
Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.Circ Cardiovasc Interv. 2018 Jan;11(1):e005374. doi: 10.1161/CIRCINTERVENTIONS.117.005374. Circ Cardiovasc Interv. 2018. PMID: 29311287
-
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895. JAMA Cardiol. 2017. PMID: 28903139 Free PMC article.
Cited by
-
Complete and incomplete revascularization in non-ST segment myocardial infarction with multivessel disease: long-term outcomes of first- and second-generation drug-eluting stents.Heart Vessels. 2019 Feb;34(2):251-258. doi: 10.1007/s00380-018-1252-z. Epub 2018 Aug 29. Heart Vessels. 2019. PMID: 30159655
-
Percutaneous coronary intervention in patients with multi-vessel coronary artery disease: a focus on physiology.Korean J Intern Med. 2018 Sep;33(5):851-859. doi: 10.3904/kjim.2018.006. Epub 2018 Mar 21. Korean J Intern Med. 2018. PMID: 29551050 Free PMC article. Review.
-
Is Complete Revascularisation Mandated for all Patients with Multivessel Coronary Artery Disease?Interv Cardiol. 2018 Jan;13(1):45-50. doi: 10.15420/icr.2017:23:1. Interv Cardiol. 2018. PMID: 29593837 Free PMC article.
-
Current Landscape and Future Directions of Coronary Revascularization in Ischemic Systolic Heart Failure: A Review.J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101197. doi: 10.1016/j.jscai.2023.101197. eCollection 2023 Nov-Dec. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39131064 Free PMC article. Review.
-
Assessing the Clinical Influence of Chronic Total Occlusions (CTOs) Revascularization and the Impact of Vascularization Completeness on Patients with Left Ventricular (LV) Systolic Dysfunction.Comput Intell Neurosci. 2022 Aug 10;2022:9128206. doi: 10.1155/2022/9128206. eCollection 2022. Comput Intell Neurosci. 2022. PMID: 35990115 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous